Indian Journal of Cancer Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2008  |  Volume : 45  |  Issue : 4  |  Page : 158--163

Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?

S Rajappa, S Gundeti, S Uppalapati, S Jiwatani, A Abhyankar, C Pal, R Digumarti 
 Department of Medical Oncology and Pathology, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad-500 016, India

Correspondence Address:
S Rajappa
Department of Medical Oncology and Pathology, Nizam«SQ»s Institute of Medical Sciences, Punjagutta, Hyderabad-500 016
India

Background: There is general belief that patients who enrolled on a clinical trial have better outcomes compared to those who are treated outside of a trial. We analyzed if there was a «SQ»trial effect«SQ» for patients with advanced non-small cell lung cancer (NSCLC) treated with chemotherapy. Materials and methods: A retrospective analysis of cohorts of patients with advanced NSCLC who received chemotherapy inside and outside of a clinical trial were analyzed for response rates (RR), progression free survival (PFS), overall survival (OS), 1 and 2 year survival. Results: There were 194 patients who received chemotherapy of which, 54 were on a clinical trial and 140 outside of it. For the whole group, the RR, median PFS, OS, one and two-year survivals were 35.4%, six months (range, 2-70), seven months (range, 2-72), 29.8% and 9.7% respectively. The differences in RR and PFS of patients who were treated inside and outside of a clinical trial were not significant (P=0.6164, 0.0881). The differences in median OS and one-year survivals between the groups were significant (P=0.0052, 0.022). For the whole group, patients who received II line chemotherapy had better OS (P£0.0001). More patients in the trial group received II line chemotherapy (P=0.0004).The difference in the median OS between the groups continued to be significant even after patients who received II line chemotherapy were censored (P=0.0437). Conclusion: Patients with advanced NSCLC who were treated inside of a clinical trial had better OS compared to those who were treated outside of it.


How to cite this article:
Rajappa S, Gundeti S, Uppalapati S, Jiwatani S, Abhyankar A, Pal C, Digumarti R. Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?.Indian J Cancer 2008;45:158-163


How to cite this URL:
Rajappa S, Gundeti S, Uppalapati S, Jiwatani S, Abhyankar A, Pal C, Digumarti R. Is there a positive effect of participation on a clinical trial for patients with advanced non-small cell lung cancer?. Indian J Cancer [serial online] 2008 [cited 2022 Jan 27 ];45:158-163
Available from: https://www.indianjcancer.com/article.asp?issn=0019-509X;year=2008;volume=45;issue=4;spage=158;epage=163;aulast=Rajappa;type=0